Armistice Capital’s Pyxis Oncology PYXS Stock Holding History
Bought
Maintained
Sold
Other funds holding PYXS
Armistice Capital's PYXS Position: Q3 2026 in Review
Armistice Capital opened a new position in Pyxis Oncology (PYXS) in Q3 2026: 1,024,000 shares worth $2.39M. The stake represents 0.03% of the portfolio and ranks #138 among its holdings.
83 funds tracked by Wall St. Rank hold PYXS as of Q3 2026.
- Armistice Capital held 1,024,000 shares of Pyxis Oncology worth $2.39M as of Q3 2026.
- Pyxis Oncology was a new Armistice Capital position in Q3 2026.
- Pyxis Oncology made up 0.03% of Armistice Capital's portfolio in Q3 2026, its #138 holding.
- 83 funds tracked by Wall St. Rank held Pyxis Oncology as of Q3 2026.
Based on Armistice Capital's 13F filing for Q3 2026, filed 16 Nov 2026.